Skip to content

Spectral AI, Inc. MDAI Stock Issued During Period Value Sale Of Common Stock And Prefunded Warrants

Stock Issued During Period Value Sale Of Common Stock And Prefunded Warrants at other companies

OS Therapies logo
OS TherapiesOSTX
$132.54K
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
HTF
Heartflow, Inc. Common StockHTFL
$16.18M
CorMedix logo
CorMedixCRMD
$750
DJT
Trump Media & Technology GroupDJT
$94.1K-57.5%
DJT
Trump Media & Technology GroupDJT
$94.1K-57.5%

Other financials

Income statement

See full
Revenue$4.0M-40.5%
Gross profit$2.0M-36.0%
Operating income-$2.0M-120%
Net income-$3.4M-218%
EPS (diluted)-$0.11-200%

Balance sheet

See full
Cash & equivalents$11.7M-17.1%
Total debt$6.0M-36.6%
Total equity-$8.8M-442%
Total assets$17.7M-14.4%

Cash flow

See full
Operating cash flow-$3.7M-148%

Valuation

See full
Market cap$55.06M+3.9%
Enterprise value$49.43M-4.8%
P/S3.3×+1.3×

Profitability

See full
Gross margin46%+0.9pp
Operating margin-57.2%-104pp
Net margin-70%+176pp

Returns & leverage

See full
Return on equity-255.5%
Debt / equity0.7×+0.7×
Current ratio0.8×-0.7×

Where this comes from

Reported directly by Spectral AI, Inc. in its filing.

Tagged under the XBRL concept mdai:StockIssuedDuringPeriodValueSaleOfCommonStockAndPrefundedWarrants.

The official record: Spectral AI, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Spectral AI, Inc.'s stock issued during period value sale of common stock and prefunded warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Spectral AI, Inc.'s stock issued during period value sale of common stock and prefunded warrants?
Spectral AI, Inc. (MDAI) reported stock issued during period value sale of common stock and prefunded warrants of $543K in Q1 2025.
What does stock issued during period value sale of common stock and prefunded warrants mean?
The total gross proceeds received from the direct sale of common stock and associated pre-funded warrants to investors. This metric measures the capital raised through primary equity offerings designed to bolster the company's cash position.